Singapore markets close in 42 minutes
Straits Times Index
3,175.34 -12.32 (-0.39%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,245.82 -140.05 (-0.85%) FTSE 100
7,831.61 -45.44 (-0.58%) Bitcoin USD
64,743.14 +3,708.50 (+6.08%) CMC Crypto 200
1,330.18 +17.56 (+1.34%)
ACADIA Pharmaceuticals Inc. (ACAD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.81B |
| Enterprise value | 2.43B |
| Trailing P/E | N/A |
| Forward P/E | 26.25 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.85 |
| Price/book (mrq) | 6.51 |
| Enterprise value/revenue | 3.35 |
| Enterprise value/EBITDA | -35.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.39 |
| 52-week change 3 | -15.03% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 33.99 |
| 52-week low 3 | 16.60 |
| 50-day moving average 3 | 21.17 |
| 200-day moving average 3 | 24.75 |
Share statistics
| Avg vol (3-month) 3 | 1.78M |
| Avg vol (10-day) 3 | 1.27M |
| Shares outstanding 5 | 164.77M |
| Implied shares outstanding 6 | 164.77M |
| Float 8 | 109.87M |
| % held by insiders 1 | 0.49% |
| % held by institutions 1 | 99.56% |
| Shares short (28 Mar 2024) 4 | 11.2M |
| Short ratio (28 Mar 2024) 4 | 4.66 |
| Short % of float (28 Mar 2024) 4 | 9.08% |
| Short % of shares outstanding (28 Mar 2024) 4 | 6.80% |
| Shares short (prior month 29 Feb 2024) 4 | 10.81M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -8.44% |
| Operating margin (ttm) | 15.13% |
Management effectiveness
| Return on assets (ttm) | -6.86% |
| Return on equity (ttm) | -14.73% |
Income statement
| Revenue (ttm) | 726.44M |
| Revenue per share (ttm) | 4.43 |
| Quarterly revenue growth (yoy) | 69.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -67.83M |
| Net income avi to common (ttm) | -61.29M |
| Diluted EPS (ttm) | -0.37 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 438.86M |
| Total cash per share (mrq) | 2.66 |
| Total debt (mrq) | 57.2M |
| Total debt/equity (mrq) | 13.25% |
| Current ratio (mrq) | 2.42 |
| Book value per share (mrq) | 2.62 |
Cash flow statement
| Operating cash flow (ttm) | 16.7M |
| Levered free cash flow (ttm) | 28.44M |
© 2024 Yahoo. All rights reserved.